SanaCurrents Adds ASD Phase II Trial as a Catalyst for Zynerba (ZYNE)

By |2020-05-21T14:33:44-04:00May 9th, 2020|Categories: SanaCurrents, SanaCurrents Updates|Tags: , |

Zynerba Catalyst Update Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) recently affirmed it [...]